1,800
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques

, , , , , , , & show all
Pages 1086-1097 | Received 09 Mar 2019, Accepted 11 Jul 2019, Published online: 24 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xingxing Li, Ling Wang, Jingjing Liu, Enyue Fang, Xiaohui Liu, Qinhua Peng, Zelun Zhang, Miao Li, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Jia Li, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Yue Suo, Guangzhi Yue, Jianhui Nie, Weijin Huang, Wenjuan Li & Yuhua Li. (2022) Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice. Emerging Microbes & Infections 11:1, pages 1890-1899.
Read now
Kyle O’Donnell & Andrea Marzi. (2020) The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms. Expert Review of Vaccines 19:3, pages 267-277.
Read now

Articles from other publishers (10)

Mingqing Lu, Yanfeng Yao, Xuekai Zhang, Hang Liu, Ge Gao, Yun Peng, Miaoyu Chen, Jiaxuan Zhao, XiaoYu Zhang, Chunhong Yin, Weiwei Guo, Peipei Yang, Xue Hu, Juhong Rao, Entao Li, Tong Chen, Sandra Chiu, Gary Wong, Zhiming Yuan, Jiaming Lan & Chao Shan. (2023) Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection. npj Vaccines 8:1.
Crossref
Hong-Qing Zhang, Qiu-Yan Zhang, Zhi-Ming Yuan & Bo Zhang. (2023) The potential epidemic threat of Ebola virus and the development of a preventive vaccine. Journal of Biosafety and Biosecurity 5:2, pages 67-78.
Crossref
Wei-Tao Dou, Xiang Wang, Tingting Liu, Suwen Zhao, Jiao-Jiao Liu, Yao Yan, Jun Li, Chi-Yu Zhang, Adam C. Sedgwick, He Tian, Jonathan L. Sessler, Dong-Ming Zhou & Xiao-Peng He. (2022) A homogeneous high-throughput array for the detection and discrimination of influenza A viruses. Chem 8:6, pages 1750-1761.
Crossref
Lynda Coughlan, Eric J. Kremer & Dmitry M. Shayakhmetov. (2022) Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens. Molecular Therapy 30:5, pages 1822-1849.
Crossref
Jiaojiao Liu, Kun Xu, Man Xing, Yue Zhuo, Jingao Guo, Meng Du, Qi Wang, Yaling An, Jinhe Li, Ping Gao, Yihan Wang, Furong He, Yingying Guo, Mingxi Li, Yuchao Zhang, Linqi Zhang, George F. Gao, Lianpan Dai & Dongming Zhou. (2021) Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell Discovery 7:1.
Crossref
Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi, Lin Cheng, Qingtai Liang, Hongqi Liu, Pui Wang, Nan Wang, Yifeng Wang, Lili Fu, Man Xing, Ruoke Wang, Bin Ju, Li Liu, Siu-Ying Lau, Wenxu Jia, Xin Tong, Lin Yuan, Yong Guo, Hai Qi, Qi Zhang, Zhen Huang, Honglin Chen, Zheng Zhang, Zhiwei Chen, Xiaozhong Peng, Dongming Zhou & Linqi Zhang. (2021) Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Frontiers in Immunology 12.
Crossref
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Sandra Moreno, Aitor Nogales, Javier Ortego & Alejandro Marín-López. (2020) Viral Vector Vaccines against Bluetongue Virus. Microorganisms 9:1, pages 42.
Crossref
Ekramy E. Sayedahmed, Ahmed Elkashif, Marwa Alhashimi, Suryaprakash Sambhara & Suresh K. Mittal. (2020) Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines. Vaccines 8:4, pages 574.
Crossref
Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, Eva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, Gema Lorenzo, Julio Benavides, Sarah Gilbert, Aitor Nogales & Javier Ortego. (2020) Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines 8:3, pages 346.
Crossref
Ana Ricobaraza, Manuela Gonzalez-Aparicio, Lucia Mora-Jimenez, Sara Lumbreras & Ruben Hernandez-Alcoceba. (2020) High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy. International Journal of Molecular Sciences 21:10, pages 3643.
Crossref